Safety assessment of docosahexaenoic acid in X-linked retinitis pigmentosa: the 4-year DHAX trial.
about
Systematic Review of Randomized Clinical Trials on Safety and Efficacy of Pharmacological and Nonpharmacological Treatments for Retinitis PigmentosaEffectiveness and safety of nutritional supplements in the treatment of hereditary retinal dystrophies: a systematic review.Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases.Docosahexaenoic Acid Slows Visual Field Progression in X-Linked Retinitis Pigmentosa: Ancillary Outcomes of the DHAX Trial.
P2860
Safety assessment of docosahexaenoic acid in X-linked retinitis pigmentosa: the 4-year DHAX trial.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Safety assessment of docosahex ...... entosa: the 4-year DHAX trial.
@en
Safety assessment of docosahex ...... entosa: the 4-year DHAX trial.
@nl
type
label
Safety assessment of docosahex ...... entosa: the 4-year DHAX trial.
@en
Safety assessment of docosahex ...... entosa: the 4-year DHAX trial.
@nl
prefLabel
Safety assessment of docosahex ...... entosa: the 4-year DHAX trial.
@en
Safety assessment of docosahex ...... entosa: the 4-year DHAX trial.
@nl
P2093
P2860
P356
P1476
Safety assessment of docosahex ...... mentosa: the 4-year DHAX trial
@en
P2093
Alison Takacs
Dennis R Hoffman
Dianna K Hughbanks-Wheaton
Gary E Fish
N Shirlene Pearson
Rand Spencer
P2860
P304
P356
10.1167/IOVS.14-14437
P407
P577
2014-07-11T00:00:00Z